Pharmaceutical giant to demolish part of its US headquarters.
AstraZeneca will demolish 450,000 square feet of laboratory space in three buildings at its North American headquarters campus off Concord Pike in Fairfax as part of its global restructuring, the drug giant has confirmed.
The three buildings account for a major chunk of the company’s Fairfax campus and house all of the company’s Delaware-based research efforts. The huge complex west of Concord Pike is only about a decade old.
The planned demolition follows news last year that AstraZeneca would end research into new psychiatric medicines and shutter its Delaware labs as part of an ongoing restructuring of its global research-and-development activities.
